Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Holding DE:XRP2?
Track your performance easily

Silence Therapeutics (XRP2) Income Statement

4 Followers

Silence Therapeutics Income Statement

Last quarter (Q4 2022), Silence Therapeutics's total revenue was £4.76M, an increase of 39.57% from the same quarter last year. In Q4, Silence Therapeutics's net income was £-13.76M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
£ 17.50M£ 17.50M£ 12.41M£ 5.48M£ 244.00K£ 0.00
Cost of Revenue
£ 10.88M£ 10.88M£ 7.46M£ 3.76M£ 0.00-
Gross Profit
£ 6.62M£ 6.62M£ 4.96M£ 1.72M£ 244.00K-
Operating Expense
£ 55.21M£ 55.21M£ 50.77M£ 34.19M£ 22.98M£ 20.57M
Operating Income
£ -48.59M£ -48.59M£ -45.81M£ -32.48M£ -22.73M£ -20.57M
Net Non Operating Interest Income Expense
£ 179.00K£ 179.00K£ -2.00K£ 113.00K£ -6.00K£ 39.00K
Other Income Expense
--£ -44.00K£ -3.68M--
Pretax Income
£ -47.37M£ -47.37M£ -45.86M£ -36.04M£ -22.87M£ -20.53M
Tax Provision
£ -6.88M£ -6.88M£ -6.45M£ -3.49M£ -3.29M£ -2.12M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
£ -40.49M£ -40.49M£ -39.41M£ -32.55M£ -19.58M£ -18.41M
Basic EPS
---£ -0.82£ -0.78£ -0.79
Diluted EPS
---£ -0.82£ -0.78£ -0.79
Basic Average Shares
---£ 26.87M£ 25.04M£ 23.44M
Diluted Average Shares
---£ 26.87M£ 25.04M£ 23.44M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---£ 347.00K£ 374.00K£ 416.00K
Total Expenses
£ 66.09M£ 66.09M£ -58.23M£ 37.95M£ 22.98M£ 20.57M
Net Income From Continuing And Discontinued Operation
£ -40.49M£ -40.49M£ -39.41M£ -32.55M£ -19.58M£ -18.41M
Normalized Income
£ -40.49M£ -54.25M£ -52.30M£ -29.22M£ -19.58M£ -18.41M
Interest Expense
£ 47.00K--£ 16.00K£ 33.00K£ 0.00
EBIT
£ -47.32M£ -47.32M£ -45.85M£ -36.02M£ -22.84M£ -20.53M
EBITDA
£ -46.84M£ -46.84M-£ -35.53M£ -22.36M£ -20.13M
Currency in GBP

Silence Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis